![](/img/cover-not-exists.png)
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared to hospital administration: results of a prospective single-center study
Lassalle, A., Thomare, P., Fronteau, C., Mahe, B., Jube, C., Blin, N., Voldoire, M., Dubruille, V., Tessoulin, B., Touzeau, C., Chauvin, C., Loirat, M., Lok, A., Bourcier, J., Lestang, E., Mocquet, R.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv563
Date:
November, 2015
File:
PDF, 244 KB
english, 2015